| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York MDRU |
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00015249 |
Purpose
The purpose of this study is to assess the effects of chronic cocaine use on the acoustic startle response and on gating of this response in humans.
| Condition | Intervention | Phase |
|
Cocaine-Related Disorders Substance-Related Disorders |
Drug: Amantadine |
Phase I |
| Study Type: | Interventional |
| Study Design: | Diagnostic, Double-Blind, Placebo Control |
| Official Title: | Prepulse Inhibition of Startle in Cocaine Dependence (Human) |
| Estimated Enrollment: | 0 |
| Study Start Date: | February 1997 |
The objective of this study is to assess the effects of chronic cocaine use on the acoustic startle response and on gating of this response in humans.
Eligibility
| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Cocaine dependence. Male. Right handed. Negative urine for cocaine
Exclusion Criteria:
Positive urine for cocaine. History of head trauma. Significant medical disease.
Contacts and Locations| United States, New York | |||||
| New York MDRU | |||||
| New York, New York, United States, 10010 | |||||
| National Institute on Drug Abuse (NIDA) |
| New York MDRU |
| Principal Investigator: | John Rotrosen, M.D. | New York MDRU |
More Information
| Study ID Numbers: | NIDA-5-0013-7, Y01-5-0013-7 |
| First Received: | April 18, 2001 |
| Last Updated: | November 3, 2005 |
| ClinicalTrials.gov Identifier: | NCT00015249 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
